Nuvio

Nuvio

United StatesUnited States
•Seed•Founded 2022•Updated 2 months ago
HealthtechAI/MLIOTHardwareB2BB2CB2B2C6-10 employees
First-Time FounderFirst-Time FounderActively Raising

About

Predictive mobility intelligence for aging care. Nuvio captures every walk passively, continuously, visible to the care team through sensor-enabled mobility aids that provide 15+ clinically relevant metrics without requiring wearables or manual testing.

Traction & Metrics

Users & Clients

150

Users

4

Clients

Products

Nuvio One

Premium rollator walker features 20% faster sit-to-stand, 25% greater functional reach, and 90% user preference vs. comparator rollators. FDA registered Class 1 device with 60% gross margin at ~$500 ASP. Post-soft launch production with peak ~$50K/month run rate, now shifting to profitable unit economics with scaled production.

Click to read more

Nuvio Pro

Clinical analytics platform launching Q1 2027 that provides 15+ clinically relevant mobility metrics captured passively from Nuvio devices. Subscription-based intelligence layer ($1.2K-$3K per walker per year) offering continuous gait monitoring, decline prediction, risk scoring, and outcomes attribution for rehab and aging care providers. API-ready with 2.5 month device payback period.

Click to read more